Techcomp (Europe) Ltd (TEU) has appointed Khalid Tafrasti as the new CEO for Scion Instruments Ltd to oversee operations in The Netherlands, UK and various sales and service offices world-wide. Khalid has more than 20 years of experience in the Petrochemical GC Analyser business most recently with AASolutions FZCo, the company he founded in Dubai. […]
BILLERICA, Mass. — Bruker today announced the appointment of Dr. Burkhard Prause, the President of the Bruker Energy & Supercon Technologies (BEST) segment, as an executive officer of Bruker Corporation. Dr. Prause has a successful track record of leading BEST through a significant expansion of its business in the last decade, with a focus on […]
BILLERICA, Mass. — Bruker Corporation (NASDAQ: BRKR) today announced that Mr. Anthony L. Mattacchione, Chief Financial Officer (CFO) and Senior Vice President of Bruker, has submitted his resignation, effective as of March 16, 2018, in order to pursue other interests. Mr. Mattacchione has informed us that he has accepted a position as Chief Financial Officer of private-equity backed CDMO company Albany Molecular Research, […]
SALT LAKE CITY and PROVO, Utah — After decades of breakthrough work in a variety of analytical techniques utilizing capillary chromatography, Dr. Milton Lee has joined forces with Glen Mella (a long-time serial entrepreneur and successful venture-backed business executive) to form Axcend — a company dedicated to revolutionizing the liquid chromatography marketplace. Mella will serve as Chief Executive […]
BERWYN, PA – AMETEK, Inc. (NYSE: AME) today announced that its Board of Directors has elected Mark Scheuer as Vice President, Environmental, Health & Safety (EH&S). Mr. Scheuer currently serves as Director, Corporate Compliance. “I am pleased to announce Mark’s promotion to Vice President. He has done an outstanding job supporting our environmental, health and […]
BOSTON, MA – Invicro LLC, a Konica Minolta company and a leading provider of imaging services and software for research and drug development, today announced the hiring of Mr. George Abe, as Senior Vice President of Pathology. Backed by more than 25 years of technology and life science business experience, Mr. Abe will lead and expand […]
New Executive Leaders, Experienced in DNA Sequencing Analysis and Scientific Innovation, Join Pathogen Detection Biotech Company VANCOUVER, British Columbia — LexaGene Holdings Inc. (OTCQB:LXXGF) (TSX-V:LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection, today announced the appointments of Dr. Nathan Walsh to the role of Director of Applications – Bioinformatics and Dr. Manoj Nair […]
SARASOTA, Fla. — Roper Technologies, Inc. (NYSE:ROP), a diversified technology company, today announced that Neil Hunn has been appointed Chief Operating Officer, effective immediately. Mr. Hunn remains an Executive Vice President. “Neil Hunn has distinguished himself as an extraordinary operating leader in our Software and Medical businesses, and we are expanding his responsibilities so that he can […]
WASHINGTON — Danaher Corporation (NYSE: DHR) today announced that, effective January 1, 2019, Matthew R. McGrew, Group CFO of the Company’s Diagnostics and Dental platforms, will succeed Daniel L. Comas as Chief Financial Officer. Mr. Comas will continue as an Executive Vice President of the Company, and a member of the Office of the Chief Executive, effective January 1, 2019 as he begins […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
